(Q51366717)

English

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

scientific article published on 17 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

metabolic syndrome

1 reference

based on heuristic

inferred from title

Vasilios G. Athyros

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Emmanuel Ganotakis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Evangelos N Liberopoulos

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Theodore Alexandrides

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Apostolos Achimastos

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Eleni Bilianou

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Asterios Karagiannis

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Konstantinos Tziomalos

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Assessing the Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT) Collaborative Group

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Dimitri P Mikhailidis

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

17 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

63

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

358-366

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Targeting vascular risk in patients with metabolic syndrome but without diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Centralized Pan-European survey on the undertreatment of hypercholesterolemia in patients using lipid lowering drugs--the CEPHEUS-Greece survey

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Exercise and weight loss improve exercise capacity independent of cardiac function in metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Coronary collaterals in obese patients: impact of metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

New onset diabetes during antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Role of renin-angiotensin system in adipose tissue dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Statin therapy and risk of developing type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Lipid-lowering agents and new onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Prevention and treatment of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

1 reference

https://api.crossref.org/works/10.1177%2F0003319711421341

21 January 2018

Identifiers

10.1177/0003319711421341

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22007026%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51366717&oldid=1187424577"